Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 65 announcements

Share price: ₹833.80
Market cap: ₹16,389 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 23.6×Sector 47.3×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 3 Merger & Restructuring 2 Management Change 2 Earnings Call 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

20 Aug 2026 19:01 IST BSE

Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals Limited has appointed Mr. Chirag Shukla as the Company Secretary and Compliance Officer (Key Managerial Personnel), effective 20th August, 2026.

Read the filing ↗

10 Aug 2026 19:00 IST BSE

Management Change

Alembic Pharmaceuticals Management Change

Alembic Pharmaceuticals' Company Secretary and Compliance Officer, Ms. Manisha Saraf, has resigned from her position effective August 10, 2026.

Read the filing ↗